Matches in Nanopublications for { ?s ?p "[However, CD13 positivity has not previously been described in a case of CD30+ (ALK-1+) anaplastic large-cell lymphoma of presumed null-cell origin without histiocytic differentiation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 7 of
7
with 100 items per page.
- NP562244.RADt9OuJElOnxPepP5xOTVT8rZ6eQ6cS44GOt1-4bJgNo130_assertion description "[However, CD13 positivity has not previously been described in a case of CD30+ (ALK-1+) anaplastic large-cell lymphoma of presumed null-cell origin without histiocytic differentiation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP562244.RADt9OuJElOnxPepP5xOTVT8rZ6eQ6cS44GOt1-4bJgNo130_provenance.
- NP783583.RArWz-RvDbO-6GmTc_-TxWHwBVoCvT9TAUb7om20lEQ1M130_assertion description "[However, CD13 positivity has not previously been described in a case of CD30+ (ALK-1+) anaplastic large-cell lymphoma of presumed null-cell origin without histiocytic differentiation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP783583.RArWz-RvDbO-6GmTc_-TxWHwBVoCvT9TAUb7om20lEQ1M130_provenance.
- NP304320.RAQ4N8ZPz9OGCHkBGcISnMoUztnGlZif8Ee6nZo80521Q130_assertion description "[However, CD13 positivity has not previously been described in a case of CD30+ (ALK-1+) anaplastic large-cell lymphoma of presumed null-cell origin without histiocytic differentiation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP304320.RAQ4N8ZPz9OGCHkBGcISnMoUztnGlZif8Ee6nZo80521Q130_provenance.
- NP304325.RAuWStTO1H2uQcId6gI-F1lv6-fSrG2MczHcDusY3tMbg130_assertion description "[However, CD13 positivity has not previously been described in a case of CD30+ (ALK-1+) anaplastic large-cell lymphoma of presumed null-cell origin without histiocytic differentiation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP304325.RAuWStTO1H2uQcId6gI-F1lv6-fSrG2MczHcDusY3tMbg130_provenance.
- NP222391.RAEmA9cnZDzPCD_iVudYbeG-gAUdloikZfhHfvDpcOg9Y130_assertion description "[However, CD13 positivity has not previously been described in a case of CD30+ (ALK-1+) anaplastic large-cell lymphoma of presumed null-cell origin without histiocytic differentiation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP222391.RAEmA9cnZDzPCD_iVudYbeG-gAUdloikZfhHfvDpcOg9Y130_provenance.
- NP702367.RA-BZivnvzrI29VIpFLmO7HDiAdL6wVfciO4H9o-A7bgQ130_assertion description "[However, CD13 positivity has not previously been described in a case of CD30+ (ALK-1+) anaplastic large-cell lymphoma of presumed null-cell origin without histiocytic differentiation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP702367.RA-BZivnvzrI29VIpFLmO7HDiAdL6wVfciO4H9o-A7bgQ130_provenance.
- NP304319.RA-LDD02KFQzJ1em7AY9rwx9dcq0H-XE8GetFqAnrpyAQ130_assertion description "[However, CD13 positivity has not previously been described in a case of CD30+ (ALK-1+) anaplastic large-cell lymphoma of presumed null-cell origin without histiocytic differentiation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP304319.RA-LDD02KFQzJ1em7AY9rwx9dcq0H-XE8GetFqAnrpyAQ130_provenance.